BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24280454)

  • 1. The changing landscape of multiple myeloma: implications for oncology nurses.
    Kurtin S; Faiman B
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():7-11. PubMed ID: 24280454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic stem cell transplantation for patients with multiple myeloma: an overview for nurses in community practice.
    Miceli T; Lilleby K; Noonan K; Kurtin S; Faiman B; Mangan PA
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():13-24. PubMed ID: 24280455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical updates in blood and marrow transplantation in multiple myeloma.
    Faiman B; Miceli T; Noonan K; Lilleby K
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():33-41. PubMed ID: 24280457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic Stem Cell Transplantation for Multiple Myeloma.
    Koniarczyk HL; Ferraro C; Miceli T
    Semin Oncol Nurs; 2017 Aug; 33(3):265-278. PubMed ID: 28729120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine health maintenance in patients living with multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Bilotti E; Gleason CL; McNeill A;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():25-40. PubMed ID: 21816708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous hematopoietic stem cell transplantation for multiple myeloma: frequently asked questions.
    Mangan PA; Gleason CL; Miceli T
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():43-7. PubMed ID: 24280458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caregivers of multiple myeloma survivors.
    Kurtin S; Lilleby K; Spong J
    Clin J Oncol Nurs; 2013 Dec; 17 Suppl():25-32. PubMed ID: 24280456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
    Raje N; Faiman B; Harvey RD; Kurtin SE; Lonial S; Kumar SK; Cohen AD; Conde MA; Giralt SA; Recine MS; Tombler ER; Stadtmauer E; Jagannath S; Anderson KC;
    Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):356-69. PubMed ID: 25066040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobility and safety in the multiple myeloma survivor: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Rome SI; Jenkins BS; Lilleby KE;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():41-52. PubMed ID: 21816709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic stem cell transplantation in multiple myeloma.
    Pant S; Copelan EA
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):877-85. PubMed ID: 17640590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survivorship care guidelines for patients living with multiple myeloma: consensus statements of the International Myeloma Foundation Nurse Leadership Board.
    Bilotti E; Faiman BM; Richards TA; Tariman JD; Miceli TS; Rome SI;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl(Suppl):5-8. PubMed ID: 21816706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive treatment strategies in multiple myeloma.
    Kovacsovics TJ; Delaly A
    Semin Hematol; 1997 Jan; 34(1 Suppl 1):49-60. PubMed ID: 9122746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of interventions that assist caregivers to support people with dementia living in the community: a systematic review.
    Parker D; Mills S; Abbey J
    Int J Evid Based Healthc; 2008 Jun; 6(2):137-72. PubMed ID: 21631819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sexual dysfunction in multiple myeloma: survivorship care plan of the International Myeloma Foundation Nurse Leadership Board.
    Richards TA; Bertolotti PA; Doss D; McCullagh EJ;
    Clin J Oncol Nurs; 2011 Aug; 15 Suppl():53-65. PubMed ID: 21816710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversy in multiple myeloma transplants: tandem autotransplants and mini-allografts.
    Vesole DH; Simic A; Lazarus HM
    Bone Marrow Transplant; 2001 Oct; 28(8):725-35. PubMed ID: 11781623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extramedullary vs medullary relapse after autologous or allogeneic hematopoietic stem cell transplantation (HSCT) in multiple myeloma (MM) and its correlation to clinical outcome.
    Zeiser R; Deschler B; Bertz H; Finke J; Engelhardt M
    Bone Marrow Transplant; 2004 Dec; 34(12):1057-65. PubMed ID: 15516937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multiple myeloma: the changing landscape.
    Reece DE
    Blood Rev; 2007 Nov; 21(6):301-14. PubMed ID: 17761373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New questions about transplantation in multiple myeloma.
    Hari P; Pasquini MC; Vesole DH
    Oncology (Williston Park); 2006 Sep; 20(10):1230-42; discussion 1242, 1244, 1249-50. PubMed ID: 17024872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma.
    Gertz MA; Lacy MQ; Dispenzieri A; Hayman SR; Kumar SK
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):343-60. PubMed ID: 16503852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Modern treatment methods for multiple myeloma: guidelines from the Dutch Haemato-Oncology Association (HOVON)].
    Lokhorst H; Huijgens PC; Raymakers R; Bos GM; Vellenga E; Wijermans PW; Sonneveld P;
    Ned Tijdschr Geneeskd; 2005 Apr; 149(15):808-13. PubMed ID: 15850271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.